APO Research
Talk to an analyst

APO RESEARCH · REPORT

Saliva Substitute

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Saliva Substitute Industry Growth and Trends Forecast to 2032

4 July 2026103 pages

Choose your research edition.

Industry ResearchSaliva Substitute Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Saliva Substitute Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Saliva Substitute Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Saliva Substitute Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Saliva Substitute Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Saliva Substitute market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Saliva Substitute is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Saliva Substitute is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Saliva Substitute is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Saliva Substitute include Biotene, Xlear, Oasis, Glandosane, TheraBreath, OraCoat, Lubricity Labs, SalivaMAX（Forward Science） and Dentiva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Saliva Substitute market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Saliva Substitute market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Saliva Substitute market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Saliva Substitute.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Saliva Substitute market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Saliva Substitute Market by Company

Biotene

Xlear

Oasis

Glandosane

TheraBreath

OraCoat

Lubricity Labs

SalivaMAX（Forward Science）

Dentiva

GC Dry Mouth Products

Colgate

Hager Pharma

SmartMouth

Saliva Substitute Segment by Type

Spray

Gel

Lozenge

Other

Saliva Substitute Segment by Application

Supermarket

Specialty Store

Online Sales

Other

Saliva Substitute Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saliva Substitute market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Saliva Substitute and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saliva Substitute.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Saliva Substitute manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Saliva Substitute in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Spray Table 2. Major Company of Gel Table 3. Major Company of Lozenge Table 4. Major Company of Other Table 5. Global Saliva Substitute Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Saliva Substitute Sales by Type (2021-2026) & (k units) Table 7. Global Saliva Substitute Sales Market Share in Volume by Type (2021-2026) Table 8. Global Saliva Substitute Sales by Type (2021-2026) & (US$ Million) Table 9. Global Saliva Substitute Sales Market Share in Value by Type (2021-2026) Table 10. Global Saliva Substitute Price by Type (2021-2026) & (USD/unit) Table 11. Global Saliva Substitute Sales by Type (2027-2032) & (k units) Table 12. Global Saliva Substitute Sales Market Share in Volume by Type (2027-2032) Table 13. Global Saliva Substitute Sales by Type (2027-2032) & (US$ Million) Table 14. Global Saliva Substitute Sales Market Share in Value by Type (2027-2032) Table 15. Global Saliva Substitute Price by Type (2027-2032) & (USD/unit) Table 16. North America Saliva Substitute Sales by Type (2021-2026) & (k units) Table 17. North America Saliva Substitute Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Saliva Substitute Sales by Type (2021-2026) & (k units) Table 19. Europe Saliva Substitute Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Saliva Substitute Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Saliva Substitute Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Saliva Substitute Sales by Type (2021-2026) & (k units) Table 23. Latin America Saliva Substitute Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Saliva Substitute Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Saliva Substitute Sales by Type (2021-2026) & (US$ Million) Table 26. Saliva Substitute Industry Trends Table 27. Saliva Substitute Industry Drivers Table 28. Saliva Substitute Industry Opportunities and Challenges Table 29. Saliva Substitute Industry Restraints Table 30. Global Saliva Substitute Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Saliva Substitute Revenue Market Share by Company (2021-2026) Table 32. Global Saliva Substitute Sales by Company (2021-2026) & (k units) Table 33. Global Saliva Substitute Sales Share by Company (2021-2026) Table 34. Global Saliva Substitute Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Saliva Substitute Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Saliva Substitute Major Company Production Sites and Headquarters Table 37. Global Saliva Substitute Company, Product Type & Application Table 38. Global Saliva Substitute Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Saliva Substitute by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Saliva Substitute Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Saliva Substitute Sales by Region (2021-2026) & (k units) Table 43. Global Saliva Substitute Sales Market Share in Volume by Region (2021-2026) Table 44. Global Saliva Substitute Sales by Region (2021-2026) & (US$ Million) Table 45. Global Saliva Substitute Sales Market Share in Value by Region (2021-2026) Table 46. Global Saliva Substitute Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Saliva Substitute Sales by Region (2027-2032) & (k units) Table 48. Global Saliva Substitute Sales Market Share in Volume by Region (2027-2032) Table 49. Global Saliva Substitute Sales by Region (2027-2032) & (US$ Million) Table 50. Global Saliva Substitute Sales Market Share in Value by Region (2027-2032) Table 51. Global Saliva Substitute Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Saliva Substitute Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Saliva Substitute Sales by Application (2021-2026) & (k units) Table 54. Global Saliva Substitute Sales Market Share in Volume by Application (2021-2026) Table 55. Global Saliva Substitute Sales by Application (2021-2026) & (US$ Million) Table 56. Global Saliva Substitute Sales Market Share in Value by Application (2021-2026) Table 57. Global Saliva Substitute Price by Application (2021-2026) & (USD/unit) Table 58. Global Saliva Substitute Sales by Application (2027-2032) & (k units) Table 59. Global Saliva Substitute Sales Market Share in Volume by Application (2027-2032) Table 60. Global Saliva Substitute Sales by Application (2027-2032) & (US$ Million) Table 61. Global Saliva Substitute Sales Market Share in Value by Application (2027-2032) Table 62. Global Saliva Substitute Price by Application (2027-2032) & (USD/unit) Table 63. North America Saliva Substitute Sales by Application (2021-2026) & (k units) Table 64. North America Saliva Substitute Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Saliva Substitute Sales by Application (2021-2026) & (k units) Table 66. Europe Saliva Substitute Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Saliva Substitute Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Saliva Substitute Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Saliva Substitute Sales by Application (2021-2026) & (k units) Table 70. Latin America Saliva Substitute Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Saliva Substitute Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Saliva Substitute Sales by Application (2021-2026) & (US$ Million) Table 73. Biotene Company Information Table 74. Biotene Business Overview Table 75. Biotene Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Biotene Saliva Substitute Product Portfolio Table 77. Biotene Recent Development Table 78. Xlear Company Information Table 79. Xlear Business Overview Table 80. Xlear Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Xlear Saliva Substitute Product Portfolio Table 82. Xlear Recent Development Table 83. Oasis Company Information Table 84. Oasis Business Overview Table 85. Oasis Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Oasis Saliva Substitute Product Portfolio Table 87. Oasis Recent Development Table 88. Glandosane Company Information Table 89. Glandosane Business Overview Table 90. Glandosane Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Glandosane Saliva Substitute Product Portfolio Table 92. Glandosane Recent Development Table 93. TheraBreath Company Information Table 94. TheraBreath Business Overview Table 95. TheraBreath Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. TheraBreath Saliva Substitute Product Portfolio Table 97. TheraBreath Recent Development Table 98. OraCoat Company Information Table 99. OraCoat Business Overview Table 100. OraCoat Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. OraCoat Saliva Substitute Product Portfolio Table 102. OraCoat Recent Development Table 103. Lubricity Labs Company Information Table 104. Lubricity Labs Business Overview Table 105. Lubricity Labs Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Lubricity Labs Saliva Substitute Product Portfolio Table 107. Lubricity Labs Recent Development Table 108. SalivaMAX（Forward Science） Company Information Table 109. SalivaMAX（Forward Science） Business Overview Table 110. SalivaMAX（Forward Science） Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. SalivaMAX（Forward Science） Saliva Substitute Product Portfolio Table 112. SalivaMAX（Forward Science） Recent Development Table 113. Dentiva Company Information Table 114. Dentiva Business Overview Table 115. Dentiva Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Dentiva Saliva Substitute Product Portfolio Table 117. Dentiva Recent Development Table 118. GC Dry Mouth Products Company Information Table 119. GC Dry Mouth Products Business Overview Table 120. GC Dry Mouth Products Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. GC Dry Mouth Products Saliva Substitute Product Portfolio Table 122. GC Dry Mouth Products Recent Development Table 123. Colgate Company Information Table 124. Colgate Business Overview Table 125. Colgate Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Colgate Saliva Substitute Product Portfolio Table 127. Colgate Recent Development Table 128. Hager Pharma Company Information Table 129. Hager Pharma Business Overview Table 130. Hager Pharma Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Hager Pharma Saliva Substitute Product Portfolio Table 132. Hager Pharma Recent Development Table 133. SmartMouth Company Information Table 134. SmartMouth Business Overview Table 135. SmartMouth Saliva Substitute Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. SmartMouth Saliva Substitute Product Portfolio Table 137. SmartMouth Recent Development Table 138. North America Saliva Substitute Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. North America Saliva Substitute Sales by Country (2021-2026) & (k units) Table 140. North America Saliva Substitute Sales Market Share by Country (2021-2026) Table 141. North America Saliva Substitute Sales Forecast by Country (2027-2032) & (k units) Table 142. North America Saliva Substitute Sales Market Share Forecast by Country (2027-2032) Table 143. North America Saliva Substitute Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Saliva Substitute Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Saliva Substitute Market Share by Country (2021-2026) Table 146. North America Saliva Substitute Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Saliva Substitute Market Share Forecast by Country (2027-2032) Table 148. Europe Saliva Substitute Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Europe Saliva Substitute Sales by Country (2021-2026) & (k units) Table 150. Europe Saliva Substitute Sales Market Share by Country (2021-2026) Table 151. Europe Saliva Substitute Sales Forecast by Country (2027-2032) & (k units) Table 152. Europe Saliva Substitute Sales Market Share Forecast by Country (2027-2032) Table 153. Europe Saliva Substitute Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Saliva Substitute Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Saliva Substitute Market Share by Country (2021-2026) Table 156. Europe Saliva Substitute Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Saliva Substitute Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Saliva Substitute Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Saliva Substitute Sales by Country (2021-2026) & (k units) Table 160. Asia-Pacific Saliva Substitute Sales Market Share by Country (2021-2026) Table 161. Asia-Pacific Saliva Substitute Sales Forecast by Country (2027-2032) & (k units) Table 162. Asia-Pacific Saliva Substitute Sales Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Saliva Substitute Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Saliva Substitute Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Saliva Substitute Market Share by Country (2021-2026) Table 166. Asia-Pacific Saliva Substitute Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Saliva Substitute Market Share Forecast by Country (2027-2032) Table 168. Latin America Saliva Substitute Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 169. Latin America Saliva Substitute Sales by Country (2021-2026) & (k units) Table 170. Latin America Saliva Substitute Sales Market Share by Country (2021-2026) Table 171. Latin America Saliva Substitute Sales Forecast by Country (2027-2032) & (k units) Table 172. Latin America Saliva Substitute Sales Market Share Forecast by Country (2027-2032) Table 173. Latin America Saliva Substitute Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Saliva Substitute Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Saliva Substitute Market Share by Country (2021-2026) Table 176. Latin America Saliva Substitute Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Saliva Substitute Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Saliva Substitute Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Saliva Substitute Sales by Country (2021-2026) & (k units) Table 180. Middle East and Africa Saliva Substitute Sales Market Share by Country (2021-2026) Table 181. Middle East and Africa Saliva Substitute Sales Forecast by Country (2027-2032) & (k units) Table 182. Middle East and Africa Saliva Substitute Sales Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Saliva Substitute Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Saliva Substitute Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East and Africa Saliva Substitute Market Share by Country (2021-2026) Table 186. Middle East and Africa Saliva Substitute Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East and Africa Saliva Substitute Market Share Forecast by Country (2027-2032) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Saliva Substitute Distributors List Table 191. Saliva Substitute Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Saliva Substitute Image Figure 2. Global Saliva Substitute Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Saliva Substitute Market Size (2021-2032) & (US$ Million) Figure 4. Global Saliva Substitute Sales (2021-2032) & (k units) Figure 5. Spray Image Figure 6. Global Spray Sales YoY Growth (2021-2032) & (k units) Figure 7. Gel Image Figure 8. Global Gel Sales YoY Growth (2021-2032) & (k units) Figure 9. Lozenge Image Figure 10. Global Lozenge Sales YoY Growth (2021-2032) & (k units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Saliva Substitute Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Saliva Substitute Market Share by Type 2025 VS 2032 Figure 15. North America Saliva Substitute Sales Market Share in Volume by Type in 2025 Figure 16. North America Saliva Substitute Sales Market Share in Value by Type in 2025 Figure 17. Europe Saliva Substitute Sales Market Share in Volume by Type in 2025 Figure 18. Europe Saliva Substitute Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Saliva Substitute Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Saliva Substitute Sales Market Share in Value by Type in 2025 Figure 21. Latin America Saliva Substitute Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Saliva Substitute Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Saliva Substitute Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Saliva Substitute Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Saliva Substitute Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Supermarket Image Figure 28. Global Supermarket Sales YoY Growth (2021-2032) & (k units) Figure 29. Specialty Store Image Figure 30. Global Specialty Store Sales YoY Growth (2021-2032) & (k units) Figure 31. Online Sales Image Figure 32. Global Online Sales Sales YoY Growth (2021-2032) & (k units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Saliva Substitute Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Saliva Substitute Market Share by Application 2025 VS 2032 Figure 37. North America Saliva Substitute Sales Market Share in Volume by Application in 2025 Figure 38. North America Saliva Substitute Sales Market Share in Value by Application in 2025 Figure 39. Europe Saliva Substitute Sales Market Share in Volume by Application in 2025 Figure 40. Europe Saliva Substitute Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Saliva Substitute Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Saliva Substitute Sales Market Share in Value by Application in 2025 Figure 43. Latin America Saliva Substitute Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Saliva Substitute Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Saliva Substitute Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Saliva Substitute Sales Market Share in Value by Application in 2025 Figure 47. North America Saliva Substitute Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Saliva Substitute Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Saliva Substitute Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Saliva Substitute Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Saliva Substitute Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Saliva Substitute Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Saliva Substitute Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Saliva Substitute Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Saliva Substitute Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Saliva Substitute Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Saliva Substitute Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Saliva Substitute Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Saliva Substitute Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Saliva Substitute Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Saliva Substitute Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Saliva Substitute Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Saliva Substitute Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Saliva Substitute Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Saliva Substitute Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Saliva Substitute Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Saliva Substitute Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Saliva Substitute Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Spray
  • Gel
  • Lozenge
  • Other
Applications
  • Supermarket
  • Specialty Store
  • Online Sales
  • Other
Companies covered
  • Biotene
  • Xlear
  • Oasis
  • Glandosane
  • TheraBreath
  • OraCoat
  • Lubricity Labs
  • SalivaMAX（Forward Science）
  • Dentiva
  • GC Dry Mouth Products
  • Colgate
  • Hager Pharma
  • SmartMouth

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Saliva Substitute Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Saliva Substitute Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Saliva Substitute Market by Type
  6. 1.3.1 Spray
  7. 1.3.2 Gel
  8. 1.3.3 Lozenge
  9. 1.3.4 Other
  10. 1.4 Global Saliva Substitute Market Size by Type
  11. 1.4.1 Global Saliva Substitute Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Saliva Substitute Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Saliva Substitute Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Saliva Substitute Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Saliva Substitute Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Saliva Substitute Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Saliva Substitute Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Saliva Substitute Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Saliva Substitute Industry Trends
  2. 2.2 Saliva Substitute Industry Drivers
  3. 2.3 Saliva Substitute Industry Opportunities and Challenges
  4. 2.4 Saliva Substitute Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Saliva Substitute Revenue (2021-2026)
  2. 3.2 Global Top Players by Saliva Substitute Sales (2021-2026)
  3. 3.3 Global Top Players by Saliva Substitute Price (2021-2026)
  4. 3.4 Global Saliva Substitute Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Saliva Substitute Major Company Production Sites & Headquarters
  6. 3.6 Global Saliva Substitute Company, Product Type & Application
  7. 3.7 Global Saliva Substitute Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Saliva Substitute Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Saliva Substitute Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Saliva Substitute Tier 1, Tier 2, and Tier 3
4 Saliva Substitute Regional Status and Outlook
  1. 4.1 Global Saliva Substitute Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Saliva Substitute Historic Market Size by Region
  3. 4.2.1 Global Saliva Substitute Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Saliva Substitute Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Saliva Substitute Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Saliva Substitute Forecasted Market Size by Region
  7. 4.3.1 Global Saliva Substitute Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Saliva Substitute Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Saliva Substitute Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Saliva Substitute by Application
  1. 5.1 Saliva Substitute Market by Application
  2. 5.1.1 Supermarket
  3. 5.1.2 Specialty Store
  4. 5.1.3 Online Sales
  5. 5.1.4 Other
  6. 5.2 Global Saliva Substitute Market Size by Application
  7. 5.2.1 Global Saliva Substitute Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Saliva Substitute Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Saliva Substitute Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Saliva Substitute Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Saliva Substitute Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Saliva Substitute Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Saliva Substitute Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Saliva Substitute Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biotene
  2. 6.1.1 Biotene Company Information
  3. 6.1.2 Biotene Business Overview
  4. 6.1.3 Biotene Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biotene Saliva Substitute Product Portfolio
  6. 6.1.5 Biotene Recent Developments
  7. 6.2 Xlear
  8. 6.2.1 Xlear Company Information
  9. 6.2.2 Xlear Business Overview
  10. 6.2.3 Xlear Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Xlear Saliva Substitute Product Portfolio
  12. 6.2.5 Xlear Recent Developments
  13. 6.3 Oasis
  14. 6.3.1 Oasis Company Information
  15. 6.3.2 Oasis Business Overview
  16. 6.3.3 Oasis Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Oasis Saliva Substitute Product Portfolio
  18. 6.3.5 Oasis Recent Developments
  19. 6.4 Glandosane
  20. 6.4.1 Glandosane Company Information
  21. 6.4.2 Glandosane Business Overview
  22. 6.4.3 Glandosane Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Glandosane Saliva Substitute Product Portfolio
  24. 6.4.5 Glandosane Recent Developments
  25. 6.5 TheraBreath
  26. 6.5.1 TheraBreath Company Information
  27. 6.5.2 TheraBreath Business Overview
  28. 6.5.3 TheraBreath Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 TheraBreath Saliva Substitute Product Portfolio
  30. 6.5.5 TheraBreath Recent Developments
  31. 6.6 OraCoat
  32. 6.6.1 OraCoat Company Information
  33. 6.6.2 OraCoat Business Overview
  34. 6.6.3 OraCoat Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 OraCoat Saliva Substitute Product Portfolio
  36. 6.6.5 OraCoat Recent Developments
  37. 6.7 Lubricity Labs
  38. 6.7.1 Lubricity Labs Company Information
  39. 6.7.2 Lubricity Labs Business Overview
  40. 6.7.3 Lubricity Labs Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lubricity Labs Saliva Substitute Product Portfolio
  42. 6.7.5 Lubricity Labs Recent Developments
  43. 6.8 SalivaMAX（Forward Science）
  44. 6.8.1 SalivaMAX（Forward Science） Company Information
  45. 6.8.2 SalivaMAX（Forward Science） Business Overview
  46. 6.8.3 SalivaMAX（Forward Science） Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 SalivaMAX（Forward Science） Saliva Substitute Product Portfolio
  48. 6.8.5 SalivaMAX（Forward Science） Recent Developments
  49. 6.9 Dentiva
  50. 6.9.1 Dentiva Company Information
  51. 6.9.2 Dentiva Business Overview
  52. 6.9.3 Dentiva Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dentiva Saliva Substitute Product Portfolio
  54. 6.9.5 Dentiva Recent Developments
  55. 6.10 GC Dry Mouth Products
  56. 6.10.1 GC Dry Mouth Products Company Information
  57. 6.10.2 GC Dry Mouth Products Business Overview
  58. 6.10.3 GC Dry Mouth Products Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GC Dry Mouth Products Saliva Substitute Product Portfolio
  60. 6.10.5 GC Dry Mouth Products Recent Developments
  61. 6.11 Colgate
  62. 6.11.1 Colgate Company Information
  63. 6.11.2 Colgate Business Overview
  64. 6.11.3 Colgate Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Colgate Saliva Substitute Product Portfolio
  66. 6.11.5 Colgate Recent Developments
  67. 6.12 Hager Pharma
  68. 6.12.1 Hager Pharma Company Information
  69. 6.12.2 Hager Pharma Business Overview
  70. 6.12.3 Hager Pharma Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hager Pharma Saliva Substitute Product Portfolio
  72. 6.12.5 Hager Pharma Recent Developments
  73. 6.13 SmartMouth
  74. 6.13.1 SmartMouth Company Information
  75. 6.13.2 SmartMouth Business Overview
  76. 6.13.3 SmartMouth Saliva Substitute Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 SmartMouth Saliva Substitute Product Portfolio
  78. 6.13.5 SmartMouth Recent Developments
7 North America by Country
  1. 7.1 North America Saliva Substitute Sales by Country
  2. 7.1.1 North America Saliva Substitute Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Saliva Substitute Sales by Country (2021-2026)
  4. 7.1.3 North America Saliva Substitute Sales Forecast by Country (2027-2032)
  5. 7.2 North America Saliva Substitute Market Size by Country
  6. 7.2.1 North America Saliva Substitute Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Saliva Substitute Market Size by Country (2021-2026)
  8. 7.2.3 North America Saliva Substitute Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Saliva Substitute Sales by Country
  2. 8.1.1 Europe Saliva Substitute Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Saliva Substitute Sales by Country (2021-2026)
  4. 8.1.3 Europe Saliva Substitute Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Saliva Substitute Market Size by Country
  6. 8.2.1 Europe Saliva Substitute Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Saliva Substitute Market Size by Country (2021-2026)
  8. 8.2.3 Europe Saliva Substitute Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Saliva Substitute Sales by Country
  2. 9.1.1 Asia-Pacific Saliva Substitute Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Saliva Substitute Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Saliva Substitute Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Saliva Substitute Market Size by Country
  6. 9.2.1 Asia-Pacific Saliva Substitute Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Saliva Substitute Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Saliva Substitute Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Saliva Substitute Sales by Country
  2. 10.1.1 South America Saliva Substitute Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Saliva Substitute Sales by Country (2021-2026)
  4. 10.1.3 South America Saliva Substitute Sales Forecast by Country (2027-2032)
  5. 10.2 South America Saliva Substitute Market Size by Country
  6. 10.2.1 South America Saliva Substitute Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Saliva Substitute Market Size by Country (2021-2026)
  8. 10.2.3 South America Saliva Substitute Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Saliva Substitute Sales by Country
  2. 11.1.1 Middle East and Africa Saliva Substitute Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Saliva Substitute Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Saliva Substitute Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Saliva Substitute Market Size by Country
  6. 11.2.1 Middle East and Africa Saliva Substitute Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Saliva Substitute Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Saliva Substitute Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Saliva Substitute Value Chain Analysis
  2. 12.1.1 Saliva Substitute Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Saliva Substitute Production Mode & Process
  7. 12.2 Saliva Substitute Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Saliva Substitute Distributors
  10. 12.2.3 Saliva Substitute Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst